GMP manufacture of Shigella flexneri 2a Artificial Invaplex (InvaplexAR) and evaluation in a Phase 1 Open-label, dose escalating study administered intranasally to healthy, adult volunteers
Christopher Duplessis, Kristen A. Clarkson, K. Ross Turbyfill*, Ashley N. Alcala, Ramiro Gutierrez, Mark S. Riddle, Tida Lee, Kristopher Paolino, Hailey P. Weerts, Amanda Lynen, Edwin V. Oaks, Chad K. Porter, Robert Kaminski
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'GMP manufacture of Shigella flexneri 2a Artificial Invaplex (InvaplexAR) and evaluation in a Phase 1 Open-label, dose escalating study administered intranasally to healthy, adult volunteers'. Together they form a unique fingerprint.